Roundtable for the Scientific Community

Date: September 13, 2004
Time: 1:00 PM - 2:30 PM
Place: Natcher Conference Center, NIH Bethesda

Program Agenda

Welcome and Introduction:

• Anna Barker, Ph.D., Deputy Director for Advanced Technologies and Strategic Partnerships, National Cancer Institute
     View Presentation

Overview

• Andrew von Eschenbach, M.D., Director, National Cancer Institute

Presentation #1:
Nanotechnology and Cancer Research: Technical and Clinical Perspectives

• Richard Smalley, Ph.D., Professor of Chemistry, Physics, Astronomy, and Nanotechnology, Rice University
• Samuel Wickline, M.D., Professor of Medicine, Physics and Biomedical Engineering, Washington University
     View Presentation

Presentation #2:
The NCI Alliance for Nanotechnology in Cancer: How It Works

• Mauro Ferrari, Ph.D., Special Expert to the NCI on Nanotechnology and Professor of Biomedical Engineering, Ohio State University
     View Presentation
• Gregory Downing, D.O., Ph.D., Director, Office of Technology and Industrial Relations, Office of the Director, National Cancer Institute
     View Presentation

Presentation # 3:
Moving Forward Safely and Collaboratively

• Janet Woodcock, M.D., Acting Deputy Commissioner for Operations,
  U.S. Food and Drug Administration
     View Presentation
• Vicki Colvin, Ph.D., Director of the Center for Biological and Environmental Nanotechnology and Associate Professor of Chemistry, Rice University
     View Presentation

Panel Discussion and Q&As